<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free survival (C) and distant metastasis-free survival rates (D) were compared in the subgroup of NPC patients with EBV DNA>4000 copies/ml. Hazards ratios (HRs) were calculated using the unadjusted Cox proportional hazards model. P values were calculated using the unadjusted log-rank test.</p
<p>(a) Kaplan-Meier curve illustrating the time to first treatment depending on the EBV-DNA copy num...
<p><b>(A)</b> Disease Free Survival curve for the total of CRC patients. <b>(B)</b> Overall Survival...
<p>Overall survival (<b>A</b>) and disease-free survival curves (<b>B</b>) of CRC patients according...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Kaplan–Meier estimates of overall survival according to the locoregional SUV<sub>max</sub> or the...
<p>Kaplan–Meier estimates of overall survival according to the distant SUV<sub>max</sub> or the plas...
<p>Cases were divided into 2 group based on the viral load in their peripheral blood.</p
a<p>Data of EBV-DNA copy number were available for 81 patients and the median value was 5,050 copies...
<p>(A) Overall survival. (B) Progression-free survival. (C) Locoregional relapse-free survival and (...
<p>Probability of disease-free survival (A, C) and overall survival (B, D) in all patients (A, B) an...
<p>(A) DSS in HPV<sub>DNA</sub>+ OSCC with absent HCA-2 intensity stratified for radiotherapy (RT) a...
<p>No significant differences in the rates of disease-specific survival were found between <i>EBER</...
<p>Kaplan-Meier curves of distant metastasis-free survival (DMFS) for patients with BC depending on ...
<p>(a) Kaplan-Meier curve illustrating the time to first treatment depending on the EBV-DNA copy num...
<p><b>(A)</b> Disease Free Survival curve for the total of CRC patients. <b>(B)</b> Overall Survival...
<p>Overall survival (<b>A</b>) and disease-free survival curves (<b>B</b>) of CRC patients according...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Kaplan–Meier estimates of overall survival according to the locoregional SUV<sub>max</sub> or the...
<p>Kaplan–Meier estimates of overall survival according to the distant SUV<sub>max</sub> or the plas...
<p>Cases were divided into 2 group based on the viral load in their peripheral blood.</p
a<p>Data of EBV-DNA copy number were available for 81 patients and the median value was 5,050 copies...
<p>(A) Overall survival. (B) Progression-free survival. (C) Locoregional relapse-free survival and (...
<p>Probability of disease-free survival (A, C) and overall survival (B, D) in all patients (A, B) an...
<p>(A) DSS in HPV<sub>DNA</sub>+ OSCC with absent HCA-2 intensity stratified for radiotherapy (RT) a...
<p>No significant differences in the rates of disease-specific survival were found between <i>EBER</...
<p>Kaplan-Meier curves of distant metastasis-free survival (DMFS) for patients with BC depending on ...
<p>(a) Kaplan-Meier curve illustrating the time to first treatment depending on the EBV-DNA copy num...
<p><b>(A)</b> Disease Free Survival curve for the total of CRC patients. <b>(B)</b> Overall Survival...
<p>Overall survival (<b>A</b>) and disease-free survival curves (<b>B</b>) of CRC patients according...